Search
for
Sort by
Research 811–840 of 1000+
- An open-label, single-arm, clinical study to evaluate the efficacy and safety of Nyumi happy hair gummies in healthy adult subjects with hair fall
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata
- 320 An open label clinical trial of Abatacept (CTLA4-Ig) for alopecia areata
- An Open-Label Evaluator Blinded Study of the Efficacy and Safety of a New Nutritional Supplement in Androgenetic Alopecia: A Pilot Study.
- G.P.2.16 Valproate, acetylcarnitine, folic acid and vitamin B12 in spinal muscular atrophy: Preliminary data of an open-label study in children
- Randomized Open-Label Trial Comparing Two Ayurvedic Churna Formulations for Hair Fall (Keshapatana) among Young Female Patients
- Randomized Open-Label Trial Comparing Two Ayurvedic Churna Formulations for Hair Fall (Keshapatana) among Young Female Patients
- Use of 5% Topical Minoxidil Application for Telogen Effluvium: An Open‐Label Single‐Arm Clinical Trial
- An Open Randomised Clinical Study to Evaluate the Combined Effect of Krishna Tila Kashayam and Shatapuspa Choornam in PCOS
- An Open-Label Comparative Study on the Effects of Platelet-Rich Plasma Therapy with Hydroquinone 4% Versus Hydroquinone 4% Alone in Melasma
- An Open-label Experience Trial to Evaluate the Effects of a Novel Supplement and Hair Serum Combination on Hair, Skin and Nails in Healthy Women
- Guides: Open Access: Learn More
- An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa
- Connecting corporations and communities: Towards a theory of social inclusive open innovation
- Pericardial Disorders Occurring During Open-Label Study of 1,869 Severely Hypertensive Patients Treated with Minoxidil
- Results of Open-Label non-Randomized Comparative Clinical Trial: “BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- The Belgian Ten‐Center Open Label Trial of Topical 2% Minoxidil Solution in Early Male Pattern Alopecia
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Efficacy and Safety of a New Topical Hair Loss-Lotion Containing Oleanolic Acid, Apigenin, Biotinyl Tripeptide-1, Diaminopyrimidine Oxide, Adenosine, Biotin and Ginkgo biloba in Patients with Androgenetic Alopecia and Telogen effluvium: A Six-month Open-Label Prospective Clinical Study
- A RANDOMIZED OPEN LABELLED COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF PRACHHANNA FOLLOWED BY GUNJA LEPA AND PRP THERAPY FOLLOWED BY APPLICATION OF MINOXIDIL SOLUTION IN THE MANAGEMENT OF INDRALUPTA W.S.R TO ALOPECIA AREATA- A COMPARITIVE CLINICAL STUDY
- A RANDOMIZED OPEN LABELLED COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF PRACHHANNA FOLLOWED BY GUNJA LEPA AND PRP THERAPY FOLLOWED BY APPLICATION OF MINOXIDIL SOLUTION IN THE MANAGEMENT OF INDRALUPTA W.S.R TO ALOPECIA AREATA- A COMPARITIVE CLINICAL STUDY
- A 6‐Month Open‐Label Clinical Study Evaluating Hair and Skin Parameters After Daily Intake of a Multifactorial Drinkable Nutraceutical in Menopausal and Postmenopausal Women With Female Pattern Hair Loss
- Evaluation of the efficacy and safety of Narasimham hair oil in promoting hair regrowth and scalp health: A prospective open-label clinical study
- Pericardial Disorders Occurring during Open Label Study of 3747 Patients Treated with Systemic Minoxidil
- 54440 An open label trial evaluating the use of microneedling in hair loss
- Commercial and Open‐Source Systems
- NEMESIS - EXAMPLE OF OPEN ACCESS JOURNAL PROMOTING NEGATIVE RESULTS IN SCHOLARLY PUBLICATIONS
- Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial
- Ageratum Conyzoides L. Extract Inhibits 5α-Reductase Gene Expression and Prostaglandin D2 Release in Human Hair Dermal Papilla Cells and Improves Symptoms of Hair Loss in Otherwise Healthy Males and Females in an Open Label Pilot Study